000 01155 a2200277 4500
005 20250513102911.0
264 0 _c19970115
008 199701s 0 0 eng d
022 _a0197-2456
024 7 _a10.1016/s0197-2456(96)00018-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBuxton, A E
245 0 0 _aOngoing risk stratification trials: the primary prevention of sudden death.
_h[electronic resource]
260 _bControlled clinical trials
_cJun 1996
300 _a47S-51S p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAnti-Arrhythmia Agents
_xtherapeutic use
650 0 4 _aCoronary Artery Bypass
650 0 4 _aCoronary Disease
_xtherapy
650 0 4 _aDeath, Sudden, Cardiac
_xprevention & control
650 0 4 _aDefibrillators, Implantable
650 0 4 _aHumans
650 0 4 _aTachycardia
_xprevention & control
773 0 _tControlled clinical trials
_gvol. 17
_gno. 3 Suppl
_gp. 47S-51S
856 4 0 _uhttps://doi.org/10.1016/s0197-2456(96)00018-9
_zAvailable from publisher's website
999 _c8869948
_d8869948